Back to Search Start Over

388P Biosimilar TAB008 compared with bevacizumab in advanced non-squamous, non-small cell, EGFR wildtype lung cancer patients.

Authors :
Zhou, Z.
Lu, S.
Qin, S.
Chen, J.
Gu, K.
Sun, P.
Pan, Y.
Yu, G.
Ma, K.
Shi, J.
Sun, Y.
Yang, L.
Chen, P.
Liu, A.
He, J.
Li, X.
Wang, L.
Source :
Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1393-S1394. 2p.
Publication Year :
2020

Subjects

Subjects :
*EPIDERMAL growth factor receptors
*NON-small-cell lung carcinoma
*BIOSIMILARS

Details

Language :
English
ISSN :
09237534
Volume :
31
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
152684894
Full Text :
https://doi.org/10.1016/j.annonc.2020.10.382
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details